Market Cap 242.89M
Revenue (ttm) 490,000.00
Net Income (ttm) -41.44M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -8,457.14%
Debt to Equity Ratio 0.00
Volume 1,075,300
Avg Vol 2,439,876
Day's Range N/A - N/A
Shares Out 51.13M
Stochastic %K 76%
Beta 1.77
Analysts Strong Sell
Price Target $10.33

Latest News on CRDF

Cardiff: Second Half Of 2024 mCRC Data Is Major Inflection Point

Aug 12, 2024, 2:57 PM EDT - 6 months ago

Cardiff: Second Half Of 2024 mCRC Data Is Major Inflection Point


Cardiff Oncology, Inc. (CRDF) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 11:18 AM EDT - 7 months ago

Cardiff Oncology, Inc. (CRDF) Q2 2024 Earnings Call Transcript


Cardiff Oncology, Inc. (CRDF) Q1 2023 Earnings Call Transcript

May 3, 2024, 1:30 AM EDT - 10 months ago

Cardiff Oncology, Inc. (CRDF) Q1 2023 Earnings Call Transcript


Cardiff Oncology to Present at Upcoming Investor Conferences

Nov 21, 2022, 10:52 AM EST - 2 years ago

Cardiff Oncology to Present at Upcoming Investor Conferences